From Triglycerides to Cardiovascular Risk: The Changing Landscape of Fibrate Therapy
According to a new report by Polaris Market Research, the global Fibrate Drugs market was valued at USD 1.5 billion in 2024 and is projected to reach USD 1.8 billion by 2034, expanding at a CAGR of 2.12% over the forecast period. Growth is underpinned by rising hyperlipidemia cases, expanding combination therapies for cardiovascular risk management, and accelerating research into...
0 Commentaires 0 Parts 204 Vue 0 Aperçu